Home » Investors & Strategic Partners

Investors & strategic partners

Science has no shortage of reagents. It has a shortage of clarity.

ABMIUM is building a more transparent route between researchers and the companies behind the products they rely on.

Start a conversation Why ABMIUM

The opportunity

The market solved access. It has not solved confidence.

Researchers can access more products than ever, but understanding who is behind a reagent, how well it fits an experiment and whether the evidence justifies the choice can still be difficult.

ABMIUM exists to make that part of scientific procurement easier to navigate. We believe better visibility can support better purchasing decisions, stronger supplier relationships and more reproducible research.

Why ABMIUM

A better buying decision can start long before checkout.

ABMIUM brings scientific context, supplier transparency and product access closer together. The ambition is simple: make it easier for research teams to understand what they are buying and why it is the right choice.

Fragmented supplyProducts can move through complex catalogue and distribution relationships.
High cost of a poor fitThe wrong reagent can cost far more than its purchase price in lost time and repeated experiments.
Growing demand for evidenceResearchers and institutions increasingly expect clearer provenance, documentation and technical support.

Strategic conversations

We are interested in people who see the same problem.

We welcome conversations with investors and strategic partners who understand life sciences, scientific infrastructure, research procurement or building trusted B2B platforms.

If there is a strong fit, we can share the detail privately.

Start a conversation

Talk to ABMIUM

Interested in the next stage of the company?

Tell us who you are and why you think there may be a fit. Relevant conversations can then move into a private discussion.

Please do not send confidential information through this form.

This page is intended to invite introductory business conversations only. It does not constitute an offer of securities, an invitation to invest or investment advice.